Osaka, Japan

Masanao Inagaki




Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 51(Granted Patents)


Location History:

  • Toyonaka, JP (2015 - 2018)
  • Toyonaka-shi, Osaka-fu, JP (2018)
  • Osaka, JP (1995 - 2024)

Company Filing History:


Years Active: 1995-2024

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Innovations by Masanao Inagaki in the Field of Pharmacology

Introduction

Masanao Inagaki is a prominent inventor based in Osaka, Japan, recognized for his significant contributions in the field of pharmacology. With a total of 19 patents to his name, Inagaki has worked on various innovative compounds that target critical systems within the human body. His latest patents focus on the development of novel nitrogen-containing condensed ring compounds with dopamine D3 antagonistic effects.

Latest Patents

Inagaki's recent patents include groundbreaking compounds designed to exhibit D3 receptor antagonistic activity. One of the notable inventions is a compound represented by a specified formula, which introduces novel cyclic compounds that effectively interact with the dopamine D3 receptor. These compounds are characterized by complex structures, including non-aromatic heterocycles and possible substitutions that enhance their pharmacological profile. The advancements presented in these patents underscore the potential of leveraging dopamine D3 antagonism as a therapeutic strategy.

Career Highlights

Masanao Inagaki is associated with Shionogi & Company Limited, a reputable organization known for its commitment to innovation in pharmaceutical research. Throughout his career, Inagaki has demonstrated an exceptional capacity for creating compounds that could lead to significant medical breakthroughs, particularly in disorders influenced by dopamine pathways.

Collaborations

In his journey, Masanao Inagaki has collaborated with fellow researchers such as Nobuhiro Haga and Yoshinori Tamura. These partnerships exemplify a strong teamwork ethic and highlight the collaborative nature of research within Shionogi & Company Limited aimed at advancing pharmaceutical science and improving patient outcomes.

Conclusion

Masanao Inagaki stands out as a distinguished inventor whose work continues to pave the way for innovative therapeutic solutions. His focus on developing novel compounds with specific biological activities contributes significantly to the field of pharmacology, offering hope for new treatments in the medical community. With a rich portfolio of patents, Inagaki's future endeavors are eagerly anticipated by both his peers and the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…